Monoclonal antibodies against alpha-4-beta-7 in humans

VN10059364BActive Publication Date: 2026-07-15ABBVIE INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202300362
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2021-07-16
Publication Date: 2026-07-15
Estimated Expiration: 2041-07-16

Application Information

Patent Timeline

16 Jul 2021

Application

VN1202300362

15 Jul 2026

Publication

VN10059364B

Inventors: MIN, Jing; NG, Teresa (Iok-Chan)

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to an antibody against α4β7 that binds to β4β7 in humans, and a method for producing such antibodies. These antibodies are useful for treating patients infected with β4β7. The invention also relates to a polynucleotide encoding this antibody, a vector consisting of a polynucleotide, a typical host cell infected by the vector, and a film containing this antibody.

Need to check novelty before this filing date? Find Prior Art